The first stop for professional medicines advice

Administering

54 results

RelevanceNewest firstOldest firstTitle
Applied filters

Off-label or unlicensed products and Schedule 17 of the Human Medicines Regulations 2012 exemptions

8 January 2020The below summary details the legal position regarding the sale, supply or administration of off-label/ unlicenced products under Schedule 17 of the HMR 2012

Suitability of BBraun NRFit Lock Syringes with BBraun NRFit Syringe Caps for storage of injectable medicines

20 January 2020The NHS Pharmaceutical Aseptic Services Group published its requirements for the introduction of NRFit neuraxial syringes and caps for the purposes of drug storage on…

Administration of depot antipsychotic injections during COVID-19 in stable adult patients

16 April 2020During COVID-19, minimise unnecessary visits, and consider short term and long term management options for individuals self-isolating or symptomatic

Patient Group Direction use in End of Life Care

10 August 2020Considerations required before implementing Patient Group Direction (PGDs) for in End of Life Care

Products in use intrathecally - Version 3 (January 2019)

6 November 2020The table is a compilation of products in-use intrathecally within the NHS. This was originally compiled in December 2014 and was updated in January 2019…

Using chloramphenicol eye products in children under 2 years

29 April 2021Chloramphenicol eye drops that contain boron or borates (borax or boric acid) can be safely used in children under 2 years where indicated.

Acute settings and transcribing

22 February 2022Consideration needs to be given to the risk factors particularly associated with transcribing in acute settings

Transcribing in the patient's home with healthcare input

22 February 2022Consideration needs to be given to the risk factors particularly associated with transcribing in the patient's home with healthcare input

Worked example of assessing the risk of transcribing

22 February 2022Example where medicines are prescribed by both the patient’s GP and specialist clinicians, and are administered in a patient’s home.

Using haem arginate (human hemin) in acute porphyria attacks

21 June 2022Understanding when and how to use haem arginate can help individuals at risk of acute neurovisceral attacks, which though uncommon may be life threatening.